Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status

Gastroenterology

Volumn 116, Issue 2, 1999, Pages 239-247

  Gillen, D ^a   Wirz, A A ^a   Ardill, J E ^a   McColl, K E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; OMEPRAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; GASTRIN BLOOD LEVEL; HELICOBACTER PYLORI; HUMAN; MALE; PEPTIC ULCER; PRIORITY JOURNAL; REBOUND; STOMACH ACID SECRETION; STOMACH FUNCTION; STOMACH PH;

EID: 0032924619     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70118-6     Document Type: Article

References (69)

1. A Garner H Fadlallah ME. Parsons 1976 and all that!—20 years of antisecretory therapy Gut 39 1996 784 786
2. CW Howden JAH Forrest JL. Reid Effect of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man Gut 25 1984 707 710
3. RP Walt M Gomes FA de EC Wood LH Logan RE. Pounder Effect of daily oral omeprazole on 24 hour intragastric acidity BMJ 287 1983 12 14
4. J Meyrick-Thomas JJ Misiewicz IF Trotman EJS Boyd JA Wilson KG Wormsley RE Pounder BK Sharma N Collier J Spencer J Thompson JH Baron A Bush L Cope MJ Daly AL. Howe Omeprazole in duodenal ulceration: acid inhibition, symptom relief, endoscopic healing and recurrence BMJ 289 1984 525 528
5. CW Howden RH. Hunt The relationship between suppression of acidity and gastric ulcer healing rates Aliment Pharmacol Ther 4 1990 25 33
6. 2 blocker resistant esophagitis Dig Dis Sci 36 1991 552 557
7. PN Maton R Vinayek H Frucht KA McArthur LS Miller ZA Saeed JD Gardner RT. Jensen Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study Gastroenterology 97 1989 827 836
8. E Carlsson H Larsson H Mattsson B Ryberg G. Sundell Pharmacology and toxicology of omeprazole—with special reference to the effects on gastric mucosa Scand J Gastroenterol 21 suppl 118 1986 31 38
9. H Larsson E Carlsson B Ryberg J Fryklund B. Wallmark Rat parietal cell function after prolonged inhibition of gastric acid secretion Am J Physiol 254 1988 G33 G39
10. EJ Prewett M Hudson CU Nwokolo AM Sawyerr RE. Pounder Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole Gastroenterology 100 1991 873 877
11. N Bell K Röhss C Cederberg R. Hunt Does tachyphylaxis and/or rebound acid secretion occur during/after treatment with omeprazole or ranitidine (abstr)? Gastroenterology 104 1993 41
12. HL Waldum JS Arnestad E Brenna I Eide U Syversen AK. Sandvik Marked increase in gastric acid secretory capacity after omeprazole treatment Gut 29 1996 649 653
13. EF Verdu D Armstrong R Fraser F Viani J-P Idstrom C Cederberg AL. Blum Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole Gut 36 1995 539 543
14. EF Verdu D Armstrong J-P Idstrom J Labenz M Stolte G Dorta G Borsch AL. Blum Effect of curing Helicobacter pylori infection on intragastric pH during omeprazole treatment Gut 37 1995 743 748
15. J Labenz B Tillenberg U Peitz J-P Idstrom EF Verdu M Stolte G Borsch AL. Blum Helicobacter pylori augments the pH-raising effect of omeprazole in duodenal ulcer patients Gastroenterology 110 1996 725 732
16. D Gillen A Wirz KEL. McColl Degree of suppression of gastric acid secretion by omeprazole is related to H. pylori status (abstr) Gastroenterology 112 suppl 1 1997 A1130
17. 14C-urea breath test in determining H. pylori status and predicting ulcer disease in dyspeptic patients Am J Gastroenterol 93 1998 20 25
18. HA Hassan H. Hobsley Positioning of subject and of nasogastric tube during a gastric secretion study BMJ 256 1970 458 460
19. G Mulholland JES Ardill D Fillmore RS Chittajallu GM Fullarton KEL. McColl Helicobacter pylori -related hypergastrinaemia is due to a selective increase in gastrin-17 Gut 34 1993 757 761
20. D Gillen EM El-Omar AA Wirz JES Ardill KEL. McColl The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori -infected healthy subjects Gastroenterology 114 1998 50 57
21. BK Sharma RP Walt RE Pounder M Gomes FA de EC Wood LH. Logan Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity Gut 25 1984 957 964
22. B Sharma M Axelson RE Pounder P Lundborg M Ohman A Santana M Talbot C. Cederberg Acid secretory capacity and plasma gastrin concentrations after administration of omeprazole to normal subjects Aliment Pharmacol Ther 1 1987 67 76
23. AK Sandvik HL Waldum PM Kleveland B. Schulze Sognen Gastrin produces an immediate and dose-dependent histamine release preceding acid secretion in the totally isolated, vascularly perfused rat stomach Scand J Gastroenterol 22 1987 803 808
24. E Brenna E. Waldum Studies of isolated parietal and enterochromaffin-like cells Scand J Gastroenterol 26 1991 1295 1306
25. C Prinz M Kajimura DR Scott F Mercier HF Helander G. Sachs Histamine secretion from rat enterochromaffin-like cells Gastroenterology 105 1993 459 461
26. ML Schubert GM. Makhlouf Neural and paracrine regulation of gastrin and gastric acid secretion Gastroenterology 111 1996 837 838
27. 2receptors Nature 236 1972 385 390
28. W Creutzfeldt F Stockmann JM Conlon UR Folsch G Bonatz M. Wulfrath Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells Digestion 35 suppl 1 1986 84 97
29. H Lee R Hakanson A Karlsson H Mattsson F. Sundler Lansoprazole and omeprazole have similar effects on plasma gastrin levels, enterochromaffin-like cells, gastrin cells and somatostatin cells in the rat stomach Digestion 51 1992 125 132
30. EC Klinkenberg-Knol HPM Festen JBMJ Jansen CBHW Lamers F Nelis P Snel A Luckers CPM Dekkers N Havu SGM. Meuwissen Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety Ann Intern Med 121 1994 161 167
31. R Eissele G Brunner B Simon E Solcia R. Arnold Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia Gastroenterology 112 1997 707 717
32. WM Weinstein AF Ippoliti SW Lee LJ Weber DA. Lieberman Acid hypersecretion, parietal cell hyperplasia and endoscopic changes after withdrawal of long-term high dose omeprazole therapy: a prospective study (abstr) Gastroenterology 110 1996 A294
33. D Drimon C Wright G Tougas R. Riddell Omeprazole produces parietal cell hypertrophy and hyperplasia in humans (abstr) Gastroenterology 108 1995 A85
34. H Larsson E Carlsson H Mattsson L Lundell F Sundler G Sundell B Wallmark T Watanabe R. Hakanson Plasma gastrin and gastric enterochromaffin-like cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomised rats Gastroenterology 90 1986 391 399
35. F Sundler E Carlsson R Hakanson H Larrson H. Mattsson Inhibition of gastric acid secretion by omeprazole and ranitidine. Effects on plasma gastrin and gastric histamine, histamine decarboxylase activity and ECL cell density in normal and antrectomised rats Scand J Gastroenterol suppl 118 1989 39 46
36. R Eissele H Patberg H Koop W Krack W Lorenz AT McKnight R. Arnold Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria Gastroenterology 103 1992 1596 1601
37. A Nishida A Kobayashi-Uchida S Akuzawa Y Takinami T Shishido T Kamado H Ito M Yamano H Yuki Y Nagakura K Honda K. Miyata Gastrin receptor antagonist YM022 prevents hypersecretion after long term acid suppression Am J Physiol 269 1995 G699 G705
38. AK Sandvik R Dimaline ER Forster D Evans GJ. Dockray Differential control of somatostatin messenger RNA in rat gastric corpus and antrum. Role of acid, food, and capsaicin-sensitive afferent neurons J Clin Invest 91 1993 244 250
39. RPH Logan MM Walker JJ Misiewicz PA Gummett QN Karim JH. Baron Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole Gut 36 1995 12 16
40. EJ Kuipers AM Uyterlinde AS Pena HJA Hazeberg E Bloemena J Lindeman EC Klinkenberg Knol SGM. Meuwissen Increase of Helicobacter pylori -associated corpus gastritis during acid suppressive therapy: implications for long term safety Am J Gastroenterol 90 1995 1401 1406
41. Y Yasunaga Y Shinomura S Kanayama M Yabu T Nakanishi Y Miyazaki Y Murayama JJ Bonilla-Palacias Y. Matsuzawa Improved fold width and increased acid secretion after eradication of the organism in H. pylori -associated enlarged fold gastritis Gut 35 1994 1571 1574
42. M Feldman B Cryer KE McArthur BA Huet E. Lee Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study Gastroenterology 110 1996 1043 1052
43. EM El-Omar K Oien A El-Nujumi D Gillen A Wirz S Dahill C Williams JES Ardill KEL. McColl Helicobacter pylori infection and chronic gastric hyposecretion Gastroenterology 113 1997 15 24
44. DR Cave M. Vargas Effect of a Campylobacter pylori protein on acid secretion by parietal cells Lancet 2 1989 187 189
45. LL Huang DR Cave AV. Kane Purification and characterisation of an acid-inhibitory protein from Helicobacter pylori (abstr) Gastroenterology 108 1995 A839
46. + ATPase Gut 35 1994 1176 1180
47. 2 synthesis by the stomach and retards gastric emptying Life Sci 48 1991 123 134
48. JL Wallace M Cucala K Mugridge L. Parente Secretagogue-specific effects of interleukin-1 on gastric acid secretion Am J Physiol 261 1991 G559 G564
49. C Prinz N Neumayer S Mahr M Classen W. Schepp Functional impairment of rat enterochromaffin-like cells by interleukin 1β Gastroenterology 112 1997 364 375
50. A El-Nujumi C Williams JE Ardill K Oien KEL. McColl Eradicating H. pylori reduces hypergastrinaemia during long-term omeprazole therapy Gut 42 1998 159 165
51. K Frislid E Aadland A. Berstad Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects Scand J Gastroenterol 21 1986 119 122
52. 2 receptor antagonist Gut 30 1989 449 454
53. AF Kummer DA Johnston IN Marks GO Young NA Tigler-Wybrandi SA. Bridger Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine Gut 33 1992 175 178
54. 2-antagonist withdrawal: a comparative study with nizatidine, ranitidine and famotidine Aliment Pharmacol Ther 5 1991 391 398
55. 2 receptor blockade Gut 32 1991 1455 1460
56. EM El-Omar S Banerjee A Wirz I Penman JES Ardill KEL. McColl Marked rebound acid hypersecretion after treatment with ranitidine Am J Gastroenterol 91 1996 355 359
57. AH James GW. Pickering The role of gastric acidity in the pathogenesis of peptic ulcer Clin Sci 8 1949 181 210
58. EM El-Omar ID Penman JES Ardill RS Chittajallu C Howie KEL. McColl Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease Gastroenterology 109 1995 681 691
59. G Cadiot A Bruhat D Rigaud T Coste A Vuagnat Y Benyedder T Vallot D LeGuludec M. Mignon Multivariate analysis of pathophysiological factors in reflux oesophagitis Gut 40 1997 167 174
60. GNJ. Tytgat Drug therapy of reflux oesophagitis: an update Scand J Gastroenterol 24 suppl 168 1989 38 49
61. NJV Bell RH. Hunt Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease Gut 33 1992 118 124
62. NJV Bell D Burget CW Howden J Wilkinson RH. Hunt Appropriate acid suppression for the management of gastro-oesophageal disease Digestion 51 suppl 1 1992 59 67
63. SJ. Sontag Rolling review: gastro-oesophageal reflux disease Aliment Pharmacol Ther 7 1993 293 312
64. RH. Hunt The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease Aliment Pharmacol Ther 9 suppl 1 1995 3 7
65. 2-receptor antagonists in the treatment of gastro-oesophageal reflux disease Aliment Pharmacol Ther 9 suppl 1 1995 9 14
66. KD. Bardhan The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease Aliment Pharmacol Ther 9 suppl 1 1995 15 25
67. M Feldman CT. Richardson Total 24-hour gastric acid secretion in patients with duodenal ulcer Gastroenterology 90 1986 540 544
68. AK Sandvik E Brenna HL. Waldum Review article: the pharmacological inhibition of gastric acid secretion-tolerance and rebound Aliment Pharmacol Ther 11 1997 1013 1018
69. A Smith D Gillen K Cochran E El-Omar KEL. McColl Ranitidine treatment induces dyspepsia in previously asymptomatic healthy volunteers (abstr) Gastroenterology 112 suppl 1 1997 A105